C Bindon

1.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

C Bindon is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, C Bindon has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in C Bindon's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Complement system in diseases (3 papers). C Bindon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Complement system in diseases (3 papers). C Bindon collaborates with scholars based in United Kingdom, Australia and South Sudan. C Bindon's co-authors include Herman Waldmann, M. Brüggemann, G Hale, Mike Clark, Gareth T. Williams, R Jefferis, Michael S. Neuberger, M R Walker, Peter Hersey and William H. McCarthy and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and British Journal of Cancer.

In The Last Decade

C Bindon

15 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

1987 501 citations M. Brüggemann, Gareth T. Williams et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by C Bindon

Since Specialization

Citations

This map shows the geographic impact of C Bindon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Bindon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Bindon more than expected).

Fields of papers citing papers by C Bindon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Bindon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Bindon. The network helps show where C Bindon may publish in the future.

Co-authorship network of co-authors of C Bindon

This figure shows the co-authorship network connecting the top 25 collaborators of C Bindon. A scholar is included among the top collaborators of C Bindon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Bindon. C Bindon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Complement activation by immunoglobulin does not depend solely on C1q binding 1990 ·European Journal of Immunology ·C Bindon, G Hale, Herman Waldmann	24
2	The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies 1989 ·European Journal of Immunology ·Mike Clark, C Bindon, Martin J.S. Dyer, Peter J. Friend, G Hale, Stephen Cobbold, Roy Calne, Herman Waldmann	33
3	A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha. 1989 ·The Journal of Immunology ·M. Brüggemann, (unknown), Mike Clark, C Bindon, Herman Waldmann	51
4	IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT‐MEDIATED LYSIS BY MONOCLONAL ANTIBODIES 1988 ·European Journal of Immunology ·C Bindon, G Hale, Herman Waldmann	126
5	Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. 1988 ·The Journal of Experimental Medicine ·C Bindon, G Hale, M. Brüggemann, Herman Waldmann	219
6	Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. breakdown → 1987 ·The Journal of Experimental Medicine ·M. Brüggemann, Gareth T. Williams, C Bindon, Mike Clark, M R Walker, R Jefferis, Herman Waldmann, Michael S. Neuberger	501
7	Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways 1987 ·Molecular Immunology ·C Bindon, G Hale, N. C. Hughes‐Jones, B.D. Gorick, Herman Waldmann	11
8	RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES 1985 ·Experimental Hematology ·Herman Waldmann, G Hale, Stephen Cobbold, (unknown), Helen Tighe, C Bindon	2
9	Therapeutic Potential of Monoclonal Antibodies to the Leucocyte Common Antigen 1985 ·PubMed ·C Bindon, G Hale, Herman Waldmann	5
10	THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGEN 1985 ·Transplantation ·C Bindon, G Hale, Mike Clark, Herman Waldmann	40
11	Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells 1984 ·International Journal of Immunopharmacology ·Peter Hersey, C Bindon, (unknown), Enisa Hasic	21
12	Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects 1983 ·British Journal of Cancer ·C Bindon, (unknown), Patricia A. Ruell, Anne Edwards, William H. McCarthy, Ruth B. S. Harris, Peter Hersey	84
13	Inhibition of interleukin 2 production by factors released from tumor cells. 1983 ·The Journal of Immunology ·Peter Hersey, C Bindon, (unknown), (unknown), John Wass, W. H. McCarthy	71
14	Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes. 1983 ·PubMed ·Peter Hersey, (unknown), (unknown), C Bindon, Walter R. Benson, (unknown)	6
15	Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2 1981 ·International Journal of Cancer ·Peter Hersey, C Bindon, Anne Edwards, Elaine Murray, (unknown), William H. McCarthy	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact